Multiple Myeloma Expert Discusses Updates From ASCO 2019

Published on

Topics include: Emerging Research

As part of our coverage of the 2019 American Society of Clinical Oncology (ASCO) conference in Chicago,Dr. Hearn Jay Cho joined Patient Power to give treatment research updates for smoldering myeloma. Dr. Cho shares findings from a clinical trial on early intervention in myeloma patients, and how this information will be used when making treatment decisions. Dr. Cho also discusses disease risk stratification in multiple myeloma and implications for therapy.

Click here to read more about the early intervention study specifically for smoldering myeloma. 

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

View more programs featuring and

Join Our Community Register for Events Read Our Latest Blog

Page last updated on July 8, 2019